KGB: CSL's Brian McNamee

Departing CSL chief Brian McNamee outlines his company's rise as a global pharma leader and explains the opportunities for Australian research.

Following his final results announcement with CSL, chief executive Brian McNamee tells Business Spectator's Alan Kohler, Robert Gottliebsen and Stephen Bartholomeusz:

How the young, government-owned CSL was able to give Swiss and German field leaders Aventis Behring and ZLB a global vision.

At what point he realised he had the chance to build CSL into a global business.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles